Extracellular Vesicles: From Biomarkers to Therapeutic Tools.
Simona BernardiCarolina BalbiPublished in: Biology (2020)
Intercellular communication is an essential hallmark of multicellular organisms and can be mediated through direct cell-cell contact or transfer of secreted molecules. In the last two decades, a third mechanism for intercellular communication has emerged that involves intercellular transfer of extracellular vesicles (EVs). EVs are membranous vesicles of 30-5000 nm in size. Based on their dimension and biogenesis, EVs can be divided into different categories, such as microvesicles, apoptotic bodies, ectosomes, and exosomes. It has already been demonstrated that protein changes, expressed on the surfaces or in the content of these vesicles, may reflect the status of producing cells. For this reason, EVs, and exosomes in particular, are considered ideal biomarkers in several types of disease-from cancer diagnosis to heart rejection. This aspect opens different opportunities in EVs clinical application, considering the importance given to liquid biopsy in the recent years. Furthermore, extracellular vesicles can be natural or engineered carriers of cytoprotective or cytotoxic factors and applied, as a therapeutic tool, from regenerative medicine to target cancer therapy. This is of pivotal importance in the so called "era of the 4P medicine". This Editorial focuses on recent findings pertaining to EVs in different medical areas, from biomarkers to therapeutic applications.
Keyphrases
- cancer therapy
- mesenchymal stem cells
- single cell
- stem cells
- cell therapy
- induced apoptosis
- heart failure
- healthcare
- cell adhesion
- drug delivery
- papillary thyroid
- squamous cell carcinoma
- cystic fibrosis
- atrial fibrillation
- photodynamic therapy
- staphylococcus aureus
- small molecule
- signaling pathway
- oxidative stress
- binding protein
- young adults
- squamous cell
- protein protein
- lymph node metastasis
- pseudomonas aeruginosa